Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials
CANCER, vol.104, no.12, pp.2650-2657, 2005 (SCI-Expanded, Scopus)
- Publication Type: Article / Review
- Volume: 104 Issue: 12
- Publication Date: 2005
- Doi Number: 10.1002/cncr.21540
- Journal Name: CANCER
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.2650-2657
- Keywords: small cell lung cancer (SCLC), maintenance/consolidation chemotherapy, metaanalysis, COOPERATIVE-ONCOLOGY-GROUP, CISPLATIN PLUS ETOPOSIDE, MAINTENANCE CHEMOTHERAPY, COMBINATION CHEMOTHERAPY, ALTERNATING CHEMOTHERAPY, INDUCTION CHEMOTHERAPY, PROGNOSTIC-FACTORS, RADIATION-THERAPY, IMPROVE SURVIVAL, CLINICAL-TRIAL
- Akdeniz University Affiliated: No
Abstract
BACKGROUND. The role of maintenance/consolidation chemotherapy was assessed in the management of small cell lung cancer (SCLC) via a metaanalytic approach.